---

$34.46

+0.5340 ( +1.57% ) 1.8M

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-10-24	Sale	-90900.00	Ciaramella Giuseppe
2023-10-04	Sale	-388.00	Bellon Christine
2023-08-09	Sale	-391.00	Simon Amy